首页> 外文会议>Annual International Conference of the IEEE Engineering in Medicine and Biology Society >Anticoagulation manager: Development of a clinical decision support mobile application for management of anticoagulants
【24h】

Anticoagulation manager: Development of a clinical decision support mobile application for management of anticoagulants

机译:抗凝管理器:开发用于抗凝管理的临床决策支持移动应用程序

获取原文

摘要

Patients with certain clotting disorders or conditions have a greater risk of developing arterial or venous clots and downstream embolisms, strokes, and arterial insufficiency. These patients need prescription anticoagulant drugs to reduce the possibility of clot formation. However, historically, the clinical decision making workflow in determining the correct type and dosage of anticoagulant(s) is part science and part art. To address this problem, we developed Anticoagulation Manager, an intelligent clinical decision workflow management system on iOS-based mobile devices to help clinicians effectively choose the most appropriate and helpful follow-up clotting tests for patients with a common clotting profile. The app can provide physicians guidance to prescribe the most appropriate medication for patients in need of anticoagulant drugs. This intelligent app was jointly designed and developed by medical professionals in CDC and engineers at Georgia Tech, and will be evaluated by physicians for ease-of-use, robustness, flexibility, and scalability. Eventually, it will be deployed and shared in both physician community and developer community.
机译:患有某些凝血障碍或疾病的患者,发生动脉或静脉血栓以及下游栓塞,中风和动脉供血不足的风险更大。这些患者需要处方抗凝药以减少血凝块形成的可能性。但是,从历史上看,确定抗凝剂的正确类型和剂量的临床决策工作流程是科学和技术的一部分。为了解决此问题,我们开发了Anti凝结管理器,这是一种基于iOS的移动设备上的智能临床决策工作流管理系统,可帮助临床医生针对具有共同凝血特征的患者有效地选择最合适,最有用的后续凝血测试。该应用程序可以为医生提供指导,为需要抗凝药物的患者开出最合适的药物。这款智能应用程序是由CDC的医学专家和佐治亚理工学院的工程师共同设计和开发的,将由医生评估其易用性,鲁棒性,灵活性和可扩展性。最终,它将在医师社区和开发人员社区中部署和共享。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号